These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38723906)

  • 1. Molecular mechanisms linking loss of TDP-43 function to amyotrophic lateral sclerosis/frontotemporal dementia-related genes.
    Koike Y
    Neurosci Res; 2024 Nov; 208():1-7. PubMed ID: 38723906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A.
    Ma XR; Prudencio M; Koike Y; Vatsavayai SC; Kim G; Harbinski F; Briner A; Rodriguez CM; Guo C; Akiyama T; Schmidt HB; Cummings BB; Wyatt DW; Kurylo K; Miller G; Mekhoubad S; Sallee N; Mekonnen G; Ganser L; Rubien JD; Jansen-West K; Cook CN; Pickles S; Oskarsson B; Graff-Radford NR; Boeve BF; Knopman DS; Petersen RC; Dickson DW; Shorter J; Myong S; Green EM; Seeley WW; Petrucelli L; Gitler AD
    Nature; 2022 Mar; 603(7899):124-130. PubMed ID: 35197626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A.
    Brown AL; Wilkins OG; Keuss MJ; Hill SE; Zanovello M; Lee WC; Bampton A; Lee FCY; Masino L; Qi YA; Bryce-Smith S; Gatt A; Hallegger M; Fagegaltier D; Phatnani H; ; Newcombe J; Gustavsson EK; Seddighi S; Reyes JF; Coon SL; Ramos D; Schiavo G; Fisher EMC; Raj T; Secrier M; Lashley T; Ule J; Buratti E; Humphrey J; Ward ME; Fratta P
    Nature; 2022 Mar; 603(7899):131-137. PubMed ID: 35197628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TDP-43 and other hnRNPs regulate cryptic exon inclusion of a key ALS/FTD risk gene, UNC13A.
    Koike Y; Pickles S; Estades Ayuso V; Jansen-West K; Qi YA; Li Z; Daughrity LM; Yue M; Zhang YJ; Cook CN; Dickson DW; Ward M; Petrucelli L; Prudencio M
    PLoS Biol; 2023 Mar; 21(3):e3002028. PubMed ID: 36930682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cracking the cryptic code in amyotrophic lateral sclerosis and frontotemporal dementia: Towards therapeutic targets and biomarkers.
    Akiyama T; Koike Y; Petrucelli L; Gitler AD
    Clin Transl Med; 2022 May; 12(5):e818. PubMed ID: 35567447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A panel of TDP-43-regulated splicing events verifies loss of TDP-43 function in amyotrophic lateral sclerosis brain tissue.
    Cao MC; Ryan B; Wu J; Curtis MA; Faull RLM; Dragunow M; Scotter EL
    Neurobiol Dis; 2023 Sep; 185():106245. PubMed ID: 37527763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: a genome-wide meta-analysis.
    Diekstra FP; Van Deerlin VM; van Swieten JC; Al-Chalabi A; Ludolph AC; Weishaupt JH; Hardiman O; Landers JE; Brown RH; van Es MA; Pasterkamp RJ; Koppers M; Andersen PM; Estrada K; Rivadeneira F; Hofman A; Uitterlinden AG; van Damme P; Melki J; Meininger V; Shatunov A; Shaw CE; Leigh PN; Shaw PJ; Morrison KE; Fogh I; Chiò A; Traynor BJ; Czell D; Weber M; Heutink P; de Bakker PI; Silani V; Robberecht W; van den Berg LH; Veldink JH
    Ann Neurol; 2014 Jul; 76(1):120-33. PubMed ID: 24931836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of cryptic splicing associated with TDP-43 depletion.
    Humphrey J; Emmett W; Fratta P; Isaacs AM; Plagnol V
    BMC Med Genomics; 2017 May; 10(1):38. PubMed ID: 28549443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal Splicing Events due to Loss of Nuclear Function of TDP-43: Pathophysiology and Perspectives.
    Koike Y
    JMA J; 2024 Jul; 7(3):313-318. PubMed ID: 39114608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer's disease.
    Agra Almeida Quadros AR; Li Z; Wang X; Ndayambaje IS; Aryal S; Ramesh N; Nolan M; Jayakumar R; Han Y; Stillman H; Aguilar C; Wheeler HJ; Connors T; Lopez-Erauskin J; Baughn MW; Melamed Z; Beccari MS; Olmedo Martínez L; Canori M; Lee CZ; Moran L; Draper I; Kopin AS; Oakley DH; Dickson DW; Cleveland DW; Hyman BT; Das S; Ertekin-Taner N; Lagier-Tourenne C
    Acta Neuropathol; 2024 Jan; 147(1):9. PubMed ID: 38175301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS-FTD.
    Irwin KE; Jasin P; Braunstein KE; Sinha IR; Garret MA; Bowden KD; Chang K; Troncoso JC; Moghekar A; Oh ES; Raitcheva D; Bartlett D; Miller T; Berry JD; Traynor BJ; Ling JP; Wong PC
    Nat Med; 2024 Feb; 30(2):382-393. PubMed ID: 38278991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear transport dysfunction: a common theme in amyotrophic lateral sclerosis and frontotemporal dementia.
    Jovičić A; Paul JW; Gitler AD
    J Neurochem; 2016 Aug; 138 Suppl 1():134-44. PubMed ID: 27087014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased cytoplasmic TARDBP mRNA in affected spinal motor neurons in ALS caused by abnormal autoregulation of TDP-43.
    Koyama A; Sugai A; Kato T; Ishihara T; Shiga A; Toyoshima Y; Koyama M; Konno T; Hirokawa S; Yokoseki A; Nishizawa M; Kakita A; Takahashi H; Onodera O
    Nucleic Acids Res; 2016 Jul; 44(12):5820-36. PubMed ID: 27257061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptic exon detection and transcriptomic changes revealed in single-nuclei RNA sequencing of C9ORF72 patients spanning the ALS-FTD spectrum.
    Gittings LM; Alsop EB; Antone J; Singer M; Whitsett TG; Sattler R; Van Keuren-Jensen K
    Acta Neuropathol; 2023 Sep; 146(3):433-450. PubMed ID: 37466726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting 14-3-3θ-mediated TDP-43 pathology in amyotrophic lateral sclerosis and frontotemporal dementia mice.
    Ke YD; van Hummel A; Au C; Chan G; Lee WS; van der Hoven J; Przybyla M; Deng Y; Sabale M; Morey N; Bertz J; Feiten A; Ippati S; Stevens CH; Yang S; Gladbach A; Haass NK; Kril JJ; Blair IP; Delerue F; Ittner LM
    Neuron; 2024 Apr; 112(8):1249-1264.e8. PubMed ID: 38366598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related demethylation of the TDP-43 autoregulatory region in the human motor cortex.
    Koike Y; Sugai A; Hara N; Ito J; Yokoseki A; Ishihara T; Yamagishi T; Tsuboguchi S; Tada M; Ikeuchi T; Kakita A; Onodera O
    Commun Biol; 2021 Sep; 4(1):1107. PubMed ID: 34548609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of nuclear TDP-43 in amyotrophic lateral sclerosis (ALS) causes altered expression of splicing machinery and widespread dysregulation of RNA splicing in motor neurones.
    Highley JR; Kirby J; Jansweijer JA; Webb PS; Hewamadduma CA; Heath PR; Higginbottom A; Raman R; Ferraiuolo L; Cooper-Knock J; McDermott CJ; Wharton SB; Shaw PJ; Ince PG
    Neuropathol Appl Neurobiol; 2014 Oct; 40(6):670-85. PubMed ID: 24750229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic TARDBP mutations in amyotrophic lateral sclerosis and frontotemporal dementia: disease-associated pathways.
    Barmada SJ; Finkbeiner S
    Rev Neurosci; 2010; 21(4):251-72. PubMed ID: 21086759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons.
    Liu EY; Russ J; Cali CP; Phan JM; Amlie-Wolf A; Lee EB
    Cell Rep; 2019 Apr; 27(5):1409-1421.e6. PubMed ID: 31042469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TDP-43-mediated neurodegeneration: towards a loss-of-function hypothesis?
    Vanden Broeck L; Callaerts P; Dermaut B
    Trends Mol Med; 2014 Feb; 20(2):66-71. PubMed ID: 24355761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.